The article:
“It is a rather unexpected effect, because aspirin is mainly used as an anti-inflammatory drug,” says Marco Scarpa, a researcher at the University of Padova, and one of the authors of the study. As Scarpa notes, this study suggests that aspirin may be playing a slightly different role by stimulating the immune system’s surveillance response, which can then prevent or delay the progression of colorectal cancer.